Observational Study of Survival Outcomes of Stage IV Cancer Patients

Observational Study of Survival Times of Stage IV Cancer Patients

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01843985

Enrollment

120

Registered

2013-05-01

Start date

2013-06-30

Completion date

2018-12-31

Last updated

2013-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stage IV Cancer (Solid Tumors Only), Survival

Keywords

Stage IV cancer, Survival

Brief summary

Patients diagnosed with Stage IV cancer (solid tumors only) are evaluated to determine whether they are candidates for traditional chemotherapy. If eligible, patients are offered traditional chemotherapy, low-dose chemotherapy, or palliative care. If ineligible, patients are offered low-dose chemotherapy or palliative care. Patients will be monitored for 5 years and survival data recorded.

Interventions

None listed

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Presenting with Stage IV cancer (solid tumors only)

Exclusion criteria

* Patient declines inclusion

Design outcomes

Primary

Measure	Time frame
survival	months 1, 2, 3, 4, 6, 9, 12, 18, 24, 36, 48, 60

Countries

China

Contacts

Primary Contactgary smith

garylsmith2@msn.com5207492035

Outcome results